DBV Technologies S.A. Cash Conversion Cycle 2011-2026 | DBVT

Annual Cash Conversion Cycle DBV Technologies S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	71.3	-	-	-	-	-	-11.2 K	5.57 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.57 K	-11.2 K	-1.84 K

Quarterly Cash Conversion Cycle DBV Technologies S.A.

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34.6	-	48.9	56.4	21.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
56.4	21.6	40.4

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Adagene ADAG	53.8	$ 1.65	7.91 %	$ 92.9 M	China
AstraZeneca PLC AZN	-58	$ 93.52	-1.2 %	$ 96.9 B	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Biogen BIIB	387	$ 184.48	-1.67 %	$ 26.9 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Catalyst Biosciences CBIO	391	$ 10.84	0.46 %	$ 714 M	USA
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Corcept Therapeutics Incorporated CORT	-186	$ 37.35	-0.4 %	$ 3.86 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 23.18	2.02 %	$ 2.75 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Celldex Therapeutics CLDX	-6.08 K	$ 25.59	-6.54 %	$ 1.65 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Cellectis S.A. CLLS	-839	$ 4.22	-4.2 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 29.43	6.09 %	$ 1.43 B	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Arrowhead Pharmaceuticals ARWR	8.75	$ 66.05	2.3 %	$ 8.83 B	USA
Crinetics Pharmaceuticals CRNX	2 K	$ 55.11	3.49 %	$ 4.45 B	USA
Abeona Therapeutics ABEO	387	$ 5.14	-1.06 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 55.17	2.47 %	$ 4.65 B	Schweiz
Axon Enterprise AXON	86.2	$ 632.29	0.09 %	$ 47.9 B	USA
ADiTx Therapeutics ADTX	-4.31 K	$ 0.81	1.96 %	$ 10.7 K	USA
Aytu BioScience AYTU	174	$ 2.7	2.27 %	$ 17 M	USA